Cadila pharma launches NuPTH , an osteoporosis biosimilar in India. The Forteo biosimilar is used for treatment of osteoporosis and in patients with increased risk of fracture. India is the Osteoporosis
Cadila pharma launches biosimilar Rituximab drug Ritucad™ which is used for treatment of blood cancer and rheumatoid arthritis. Ahmedabad-based Cadila Pharmaceuticals recently announced the launch of biosimilar Rituximab for India
Cadila expands oncology portfolio with Bevasizumab biosimilar cancer drug Bevaro™ used in the treatment of multiple cancers . Ahmedabad-based Cadila Pharmaceuticals Limited recently announced the launch of Bevasizumab biosimilar for
Cadila’s Fenticad is the vaginal capsule for Vulvovaginal Candidiasis (VVC) recently launched by Cadila Pharmaceuticals. Almost 37% of women in rural India suffers from VVC in their reproductive age. Ahmedabad-based
Cadila Pharmaceuticals Ltd. launches Esomeprazole tablets under brand name Esiloc™ in India for treatment of hyperacidity. Ahmedabad-based Cadila pharmaceuticals recently announced the launch of Esomeprazole tablets for treatment of hyperacidity
Cadila pharma announces the launch of FDA registered immunity booster syrup ‘Cadimmune’. The syrup helps further augment immunity and supports in prevention of life-threatening complications in the case of viral
Cadila Pharmaceutical’s launches anti allergic drug Bilastine in India which is an anti histamine drug used in the treatment of allergic rhinitis. Ahmedabad: Cadila Pharma has recently announced the launch
Cadila Pharmaceuticals celebrates environment day with a tree plantation drive. To contribute towards making India clean and green, Cadila pharma had taken a pledge to plant 1 lakh trees in
Cadila pharma supports local communities, distributes essential kits to 1500 families living in difficult conditions and facing a hard time due to lockdown. June 5, 2020 Ahmedabad: With thousands of
